| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MLR.0B013E3180616C0A |
| P698 | PubMed publication ID | 17909389 |
| P50 | author | Martin Kulldorff | Q43862528 |
| Richard Platt | Q91067808 | ||
| Eric S Weintraub | Q105288956 | ||
| Tracy A Lieu | Q105724609 | ||
| P2093 | author name string | Robert L Davis | |
| Jeffrey S Brown | |||
| Ruihua Yin | |||
| Edwin M Lewis | |||
| Katherine Yih | |||
| Vaccine Safety Datalink Rapid Cycle Analysis Team | |||
| P433 | issue | 10 Supl 2 | |
| P921 | main subject | vaccine | Q134808 |
| vaccine safety | Q105256838 | ||
| P304 | page(s) | S89-95 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Medical Care | Q15762119 |
| P1476 | title | Real-time vaccine safety surveillance for the early detection of adverse events | |
| P478 | volume | 45 |
| Q30378494 | "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events |
| Q31135365 | A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data |
| Q34051880 | A comparison of active adverse event surveillance systems worldwide |
| Q38100037 | A global regulatory science agenda for vaccines |
| Q30420436 | A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic |
| Q33405209 | A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design |
| Q44604741 | Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization |
| Q34135347 | Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules |
| Q83139703 | Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system |
| Q42205237 | Active surveillance of adverse events following childhood immunization in Singapore |
| Q45245349 | An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink |
| Q51512036 | Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. |
| Q38416020 | Capacity for a global vaccine safety system: the perspective of national regulatory authorities. |
| Q92606940 | Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barré Syndrome after influenza vaccination during the 2010/11 influenza season |
| Q40094601 | Comparison of epidemiologic methods for active surveillance of vaccine safety |
| Q37315456 | Composite sequential Monte Carlo test for post-market vaccine safety surveillance |
| Q36955813 | Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance |
| Q64967141 | Counter-Point: Early Warning Systems Are Imperfect, but Essential. |
| Q30393154 | Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan |
| Q37149522 | Development of a large-scale de-identified DNA biobank to enable personalized medicine. |
| Q34226785 | Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples. |
| Q35045666 | Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example |
| Q26782451 | Enhancing vaccine safety capacity globally: A lifecycle perspective |
| Q44032016 | H1N1 vaccine safety monitoring: beyond background rates |
| Q30682226 | Identification of seizures among adults and children following influenza vaccination using health insurance claims data. |
| Q31159604 | Integration of data from a safety net health care system into the Vaccine Safety Datalink |
| Q44475855 | Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity |
| Q43174245 | Monitoring the safety of pandemic H1N1 vaccine |
| Q33160437 | Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. |
| Q30402907 | Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza |
| Q34039973 | Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases |
| Q53414337 | Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis. |
| Q30588232 | Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual |
| Q30383245 | Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. |
| Q28075754 | Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods |
| Q37699644 | Post-licensure monitoring of HPV vaccine in the United States |
| Q46603924 | Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine |
| Q52650773 | Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children. |
| Q64237747 | Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018 |
| Q38078815 | Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture? |
| Q37555491 | Predictive value of seizure ICD-9 codes for vaccine safety research |
| Q33166996 | Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States |
| Q26799634 | Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) |
| Q30369467 | Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials. |
| Q43996716 | Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine |
| Q30583229 | Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink project |
| Q34286201 | Sequential generalized likelihood ratio tests for vaccine safety evaluation |
| Q45218285 | Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. |
| Q56545391 | Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010 |
| Q28647427 | Sustaining Vaccine Confidence in the 21st Century |
| Q33392194 | Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases |
| Q64125697 | The MMR Vaccine and Autism |
| Q30365533 | The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. |
| Q42690594 | The role of national registries in improving patient safety for hip and knee replacements |
| Q92340072 | Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson Data |
| Q47921487 | Type I error probability spending for post-market drug and vaccine safety surveillance with binomial data. |
| Q33514762 | Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality |
| Q33403378 | Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study |
| Q92241754 | Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review |
| Q96770602 | Use of telephone helpline data for syndromic surveillance of adverse events following immunization in Australia: A retrospective study, 2009 to 2017 |
| Q38804897 | Vaccine Case-Population: A New Method for Vaccine Safety Surveillance |
| Q37327861 | Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink's Rapid Cycle Analysis Capabilities |
Search more.